# Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

> **NCT05258799** · NA · UNKNOWN · sponsor: **Huihan Wang** · enrollment: 130 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** rhTPO

## Key facts

- **NCT ID:** NCT05258799
- **Lead sponsor:** Huihan Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-21
- **Primary completion:** 2024-01-21
- **Final completion:** 2026-01-21
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258799, "Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05258799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*